PTC Therapeutics PTC Therapeutics to Participate at Upcoming May 2024 Investor Conferences

2024-05-02

WARREN, N.J., May 2, 2024 /PRNewswire/ -- PTC Therapeutics, Inc.PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: RBC Capital Markets 2024 Global Healthcare Conference Tuesday, May 14, at 11:00 am EDT Bank of America Securities 2024 Health Care Conference Thursday, May 16, at 11:40 am EDT / 08:40 am PDT The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics PTC Therapeutics' website at and will be archived for 30 days following the presentation. It is recommended that users connect to PTC PTC's website several minutes prior to the start of the webcast to ensure a timely connection. About PTC Therapeutics, Inc.PTC Therapeutics, Inc. PTC PTC is a global biopharmaceutical company focused on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC PTC, please visit us at and follow us on Instagram, Facebook, Twitter, and LinkedIn. For More Information: Investors: Kylie O'Keefe +1 (908) 300-0691 kokeefe@ptcbio.com Media: Jeanine Clemente +1 (908) 912-9406 jclemente@ptcbio.com View original content: SOURCE PTC Therapeutics, Inc.PTC Therapeutics, Inc. Company Codes: NASDAQ-NMS:PTCT

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构